Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
Chubb
US Department of Justice
UBS
Federal Trade Commission
Baxter
Cipla
Covington
Queensland Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

ZALEPLON - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for zaleplon and what is the scope of zaleplon patent protection?

Zaleplon
is the generic ingredient in two branded drugs marketed by Pfizer, Aurobindo Pharma, Cipla Ltd, Hikma Pharms, Mylan, Orchid Hlthcare, Teva Pharms, Unichem, Upsher-smith Labs, and West-ward Pharms Int, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for zaleplon. Twenty-two suppliers are listed for this compound.

US Patents and Regulatory Information for ZALEPLON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms ZALEPLON zaleplon CAPSULE;ORAL 077239-001 Jun 6, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher-smith Labs ZALEPLON zaleplon CAPSULE;ORAL 078095-002 Jun 6, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms ZALEPLON zaleplon CAPSULE;ORAL 077239-002 Jun 6, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma ZALEPLON zaleplon CAPSULE;ORAL 078829-001 Jun 6, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher-smith Labs ZALEPLON zaleplon CAPSULE;ORAL 078706-001 Jun 6, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher-smith Labs ZALEPLON zaleplon CAPSULE;ORAL 078706-002 Jun 6, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher-smith Labs ZALEPLON zaleplon CAPSULE;ORAL 078095-001 Jun 6, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma ZALEPLON zaleplon CAPSULE;ORAL 078829-002 Jun 6, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pfizer SONATA zaleplon CAPSULE;ORAL 020859-001 Aug 13, 1999 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unichem ZALEPLON zaleplon CAPSULE;ORAL 078989-001 Jun 6, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chubb
Mallinckrodt
Medtronic
Dow
US Army
Cipla
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot